Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chiara Pighi

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
Leukemia & Lymphoma|December 19, 2012
Mantle cell lymphoma cell lines show no evident immunoglobulin heavy chain stereotypy but frequent light chain stereotypyChiara Pighi, Stefano Barbi, Anna Bertolaso, et al.
Journal of Immunology Research|March 19, 2019
Memory NK Cell Features Exploitable in Anticancer ImmunotherapyCristina Capuano, Chiara Pighi, Simone Battella, et al.
Current Opinion in HIV and AIDS|January 8, 2025
Monocytes across life span in HIV infection: lights and shadowsAlessia Neri, Giulio Olivieri, Chiara Pighi, et al.
Cancers|June 2, 2021
Harnessing CD16-Mediated NK Cell Functions to Enhance Therapeutic Efficacy of Tumor-Targeting mAbsCristina Capuano, Chiara Pighi, Simone Battella, et al.
Plos One|March 24, 2015
VDJSeq-Solver: in silico V(D)J recombination detection toolGiulia Paciello, Andrea Acquaviva, Chiara Pighi, et al.
Frontiers in Immunology|June 6, 2018
Tumor-Targeting Anti-CD20 Antibodies Mediate <i>In Vitro</i> Expansion of Memory Natural Killer Cells: Impact of CD16 Affinity Ligation Conditions and <i>In Vivo</i> PrimingCristina Capuano, Simone Battella, Chiara Pighi, et al.
Cancer Research|August 1, 2015
Anti-CD20 Therapy Acts via FcγRIIIA to Diminish Responsiveness of Human Natural Killer CellsCristina Capuano, Maddalena Romanelli, Chiara Pighi, et al.
Cancer Immunology, Immunotherapy : CII|January 18, 2020
CD16 pre-ligation by defucosylated tumor-targeting mAb sensitizes human NK cells to γ<sub>c</sub> cytokine stimulation via PI3K/mTOR axisCristina Capuano, Chiara Pighi, Roberta Maggio, et al.
Oncoimmunology|April 14, 2017
Obinutuzumab-mediated high-affinity ligation of FcγRIIIA/CD16 primes NK cells for IFNγ productionCristina Capuano, Chiara Pighi, Rosa Molfetta, et al.
Cancer Cytopathology|April 28, 2026
Exploring alternatives to tumor tissue for BRCA1/2 next-generation sequencing testing in high-grade serous ovarian cancer: A 34-case series of malignant ascitesChiara Pighi, Giulio Settanni, Marta Angelini, et al.
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
Leukemia & Lymphoma|December 19, 2012
Mantle cell lymphoma cell lines show no evident immunoglobulin heavy chain stereotypy but frequent light chain stereotypyChiara Pighi, Stefano Barbi, Anna Bertolaso, et al.
Journal of Immunology Research|March 19, 2019
Memory NK Cell Features Exploitable in Anticancer ImmunotherapyCristina Capuano, Chiara Pighi, Simone Battella, et al.
Current Opinion in HIV and AIDS|January 8, 2025
Monocytes across life span in HIV infection: lights and shadowsAlessia Neri, Giulio Olivieri, Chiara Pighi, et al.
Cancers|June 2, 2021
Harnessing CD16-Mediated NK Cell Functions to Enhance Therapeutic Efficacy of Tumor-Targeting mAbsCristina Capuano, Chiara Pighi, Simone Battella, et al.
Plos One|March 24, 2015
VDJSeq-Solver: in silico V(D)J recombination detection toolGiulia Paciello, Andrea Acquaviva, Chiara Pighi, et al.
Frontiers in Immunology|June 6, 2018
Tumor-Targeting Anti-CD20 Antibodies Mediate <i>In Vitro</i> Expansion of Memory Natural Killer Cells: Impact of CD16 Affinity Ligation Conditions and <i>In Vivo</i> PrimingCristina Capuano, Simone Battella, Chiara Pighi, et al.
Cancer Research|August 1, 2015
Anti-CD20 Therapy Acts via FcγRIIIA to Diminish Responsiveness of Human Natural Killer CellsCristina Capuano, Maddalena Romanelli, Chiara Pighi, et al.
Cancer Immunology, Immunotherapy : CII|January 18, 2020
CD16 pre-ligation by defucosylated tumor-targeting mAb sensitizes human NK cells to γ<sub>c</sub> cytokine stimulation via PI3K/mTOR axisCristina Capuano, Chiara Pighi, Roberta Maggio, et al.
Oncoimmunology|April 14, 2017
Obinutuzumab-mediated high-affinity ligation of FcγRIIIA/CD16 primes NK cells for IFNγ productionCristina Capuano, Chiara Pighi, Rosa Molfetta, et al.
Cancer Cytopathology|April 28, 2026
Exploring alternatives to tumor tissue for BRCA1/2 next-generation sequencing testing in high-grade serous ovarian cancer: A 34-case series of malignant ascitesChiara Pighi, Giulio Settanni, Marta Angelini, et al.
Pageof 4